Results 91 to 100 of about 112,843 (300)
International Journal of Nephrology and Renovascular Disease, 2021 Yaser Ammar,1 Amira Mohamed,1 Gihane Khalil,2 Dalia Maharem1 1Internal Medicine Department, Medical Research Institute, Alexandria University, Alexandria, Egypt; 2Chemical Pathology Department, Medical Research Institute, Alexandria University ...
Ammar Y, Mohamed A, Khalil G, Maharem D
doaj
Arthritis &Rheumatology, EarlyView.Objective To assess the association between early antimalarial adherence and future acute care utilization and cost in a population‐based cohort of incident rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Methods All patients with incident RA/SLE and new antimalarial use in British Columbia, Canada, between January 1997 and March 2022
Md Rashedul Hoque +7 more
wiley +1 more source
Case of Hemorrhagic Vasculitis with Difficult Stream of 9 Years Old Boy
Медицинский вестник Юга России, 2012 We are presenting a case of hemorrhagic vasculitis with difficult stream of 9 years old boy. Feature of this case is manifestation of the disease after quinsy with pronounced lymphoproliferative syndrome (enlargement of anterior and posterior cervical ...
A. A. Lebedenko +2 more
doaj
Brazilian Journal of Veterinary Pathology, 2014 A case of chronic renal failure associated with septic polyarthritis affecting a 39-year-old male Western lowland gorilla (Gorilla gorilla gorilla) is described.
Tatiane Alves Paixão +7 more
doaj +1 more source
Mycophenolate mofetil in the treatment of lupus nephritis
, 2008 Patrick FK Yong1,2, David P D’Cruz21Department of Clinical Immunology, Kings College Hospital; 2The Lupus Research Unit, St Thomas’ Hospital, London, UKAbstract: Lupus nephritis is a complication of systemic lupus erythematosus, which
Patrick FK Yong +1 more
core
, 2012 BACKGROUND: In the MAINTAIN Nephritis Trial, azathioprine (AZA) and mycophenolate mofetil (MMF) were compared as maintenance immunosuppressive treatment of proliferative lupus nephritis (LN) after a short-course of intravenous cyclophosphamide.
Fiehn, Christoph +25 more
core +1 more source
, 2022 This datasheet on avian nephritis covers Identity, Overview, Associated Diseases, Pests or Pathogens, Distribution, Hosts/Species Affected, Diagnosis, Pathology, Epidemiology, Impacts, Prevention/Control, Further ...
Behboudi, Shahriar
core +1 more source
Arthritis &Rheumatology, EarlyView.Objective Lupus nephritis (LN) is one of the most severe manifestations of systemic lupus erythematosus (SLE) and is partially driven by type I interferon signaling. Anifrolumab, an approved treatment for patients with SLE, has been investigated in a phase 2 trial in patients with LN receiving standard therapy (TULIP‐LN, ClinicalTrials.gov identifier ...
Andrea Fava +8 more
wiley +1 more source
FCGR3B copy number variation is associated with systemic lupus erythematosus risk in Afro-Caribbeans. [PDF]
, 2011 OBJECTIVES: To evaluate FCGR3B copy number variation (CNV) in African and European populations and to determine if FCGR3B copy number is associated with SLE and SLE nephritis risk in Afro-Caribbeans, adjusting for African genetic ancestry.
A. L. Patrick +21 more
core +1 more source
Multi‐Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis
Arthritis &Rheumatology, EarlyView.Objective Systemic lupus erythematosus (SLE) is a multiorgan disease with widespread immune dysregulation and significant unmet clinical need. Blood‐based gene expression studies have advanced our understanding of SLE pathogenesis but may overlook critical tissue‐specific mechanisms that drive disease heterogeneity and progression.
Michael A. Smith +23 more
wiley +1 more source